8-KItem 8.01 · Other EventsItem 9.01 · Financial Statements
AbbVie launches $10 billion bond offering to fund Apogee acquisition
Filed with the SEC on · Summarized by InvestorsBot
AbbVie agreed on August 4, 2026, to issue $10 billion of senior notes across maturities from 2028 through 2066, with interest rates ranging from floating rate to 6.10%; the sale is expected to close on August 18. The company expects approximately $9.93 billion in net proceeds, primarily to fund its acquisition of Apogee Therapeutics and related costs, reducing commitments under its $10 billion delayed-draw term loan facility.